Diagnosis and treatment of pregnancy associated breast cancer

doi:10.3760/cma.j.issn.1673-422X.2013.11.016

Abstract

Abstract: Pregnancy associated breast cancer (PABC) has many special characteristics, such as the clinical manifestation， pathology， diagnosis, treatment and prognosis. Due to the delay of diagnosis, the survival rate is low and the prognosis is poor. Early diagnosis and comprehensive individualized treatment with operation, radiotherapy and chemotherapy are needed to improve the prognosis of patients and prolong the survival period.

Key words: Pregnant women, Breast neoplasms, Diagnosis, Therapy

ZHANG Shuo, WANG Meng-Sen, YU Yong-Hua. Diagnosis and treatment of pregnancy associated breast cancer[J]. Journal of International Oncology, 2013, 40(11): 853-857.

References

［1］ Sophie E, McGrath, Alistair R. Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists. Ther Adv Med Oncol, 2011, 3(2)：73-83. ［2］ Polyak K. Pregnancy and breast cancer: the other side of the coin. Cancer Cell, 2006, 9 (3)：151-153. ［3］李俊杰, 邵志敏. 妊娠期乳腺癌的诊治进展. 中国癌症杂志, 2007, 17(10)：824-827. ［4］ Navrozoglou I, Vrekoussis T, Kontostolis E, et al. Breast cancer during pregnancy: a minireview. Eur J Surg Oncol, 2008,34(8)：837-843. ［5］ Molckovsky A, Madarnas Y. Breast cancer in pregnancy: a literature review. Breast Cancer Res Treat， 2008，108(3)：333-338. ［6］李元仙, 项尖尖. 超声诊断妊娠哺乳期乳腺癌的价值. 中国妇幼保健, 2010, 25：1993-1994. ［7］姜军, 范林军. 妊娠哺乳期乳腺癌的几个临床问题. 中国实用妇科与产科杂志, 2008, 24(11)： 813-815. ［8］朱丽英. 妊娠哺乳期乳腺癌37例临床分析. 实用肿瘤学杂志, 2007, 21(5)：443-444. ［9］ Cardonick E, Gilmandyar D, Somer RA. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet Gynecol, 2012, 120(6)：1267-1272. ［10］牛占恩, 袁堂玲, 李霞, 等. 妊娠哺乳期乳腺癌6例临床分析并文献回顾. 现代肿瘤医学, 2008, 16(8)：1323-1326. ［11］ Gemignani ML. Breast cancer screening: why, when, and how many?. Clin Obstet Gynecol, 2011, 54(1)：125-132. ［12］ Azim HA Jr, Peccatori FA. Treatment of metastatic breast cancer during pregnancy: we need to talk!. Breast, 2008, 17(4)：426-428. ［13］ Gentilini O, Botteri E, Veronesi P, et al. Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates. Ann Surg Oncol, 2012 , 19(12)：3771-3776. ［14］ Azim HA Jr, Botteri E, Renne G, et al. The biological features and prognosis of breast cancer diagnosed during pregnancy: a casecontrol study. Acta Oncol, 2012, 51(5)：653-661. ［15］ Mondi MM, Cuenca RE, Ollila DW, et al. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol, 2007,14(1)：218-221. ［16］ Morris PG, King F, Kennedy MJ. Cytotoxic chemotherapy for pregnancyassociated breast cancer: single institution case series. J Oncol Pharm Pract, 2009, 15(4)：241-247. ［17］ Mir O, Berveiller P, Ropert S, et al. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol, 2008, 19(4):607-613. ［18］ Loibl S, Han SN, von Minckwitz G. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol, 2012,13(9)：887-896. ［19］ Cardonick E, Dougherty R, Grana G. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer, 2010,16 (1)：76-82. ［20］ Skrablin S, Banovic V, Matkovic V. Adriamycin and cyclophosphamide chemotherapy in advanced breast cancer in pregnancy. Eur J Obstet Gynecol Reprod Biol, 2007,33(2)：251-252. ［21］ Mathelin C, Treisser A, Chenard MP, et al. Pregnancy and postpartum breast cancer: a prospective study. Anticancer Res, 2008, 28(4C):2447-2452. ［22］ Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer, 2010, 46(18)：3158-3168. ［23］ Rajaraman P, Simpson J, Neta G, et al. Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer: casecontrol study. BMJ, 2011, 342:d472. ［24］余艳红, 周俊, 龚时鹏. 妊娠合并乳腺癌的诊治. 实用妇产科杂志, 2007, 23(9)：526-528. ［25］ Leal SC, Stuart SR, Carvalho Hde A. Breast irradiation and lactation: a review. Expert Rev Anticancer Ther， 2013,13(2)：159-164. ［26］ Luis SA, Christie DR, Kaminski A, et al. Pregnancy and radiotherapy: management options for minimising risk, case series and comprehensive literature review. J Med Imaging Radiat Oncol, 2009,53(6)：559-568. ［27］ Ives A, Saunders C, Bulsara M. Pregnancy after breast cancer: population based study. BMJ, 2007,334(7586):194.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei. Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study [J]. Journal of International Oncology, 2024, 51(6): 326-331.
[3]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[4]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[5]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[6]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[7]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[8]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[9]	Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua. Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy [J]. Journal of International Oncology, 2024, 51(5): 257-266.
[10]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[11]	Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng. Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor [J]. Journal of International Oncology, 2024, 51(5): 298-302.
[12]	Wang Peixin, Zhao Jun, Xu Shihong, Jiang Zhaoyang, Wang Xiaoqiang, Yang Hongjuan. Progress of ferroptosis-related mechanisms in osteosarcoma [J]. Journal of International Oncology, 2024, 51(5): 308-311.
[13]	Yang Hao, Shi Guidong, Zhang Chengcheng, Zhang Yue, Zhang Liwen, Fu Maoyong. Comparison of efficacy and safety between sintilimab and tislelizumab in neoadjuvant therapy for advanced esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2024, 51(4): 210-216.
[14]	Sa Qiang, Xu Hangcheng, Wang Jiayu. Advances in immunotherapy for breast cancer [J]. Journal of International Oncology, 2024, 51(4): 227-234.
[15]	Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong. Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer [J]. Journal of International Oncology, 2024, 51(4): 235-238.